Article
A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests
8 Aug 2011
Abstract excerpt
BACKGROUND: Allergic contact dermatitis is an inflammatory skin disease that affects a significant proportion of the population. This disease is caused by an adverse immune response towards chemical haptens, and leads to a substantial economic burden for society. Current test of sensitizing chemicals rely on animal experimentation. New legislations on the registration and use of chemicals within pharmaceutical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
